Nika Pharmaceuticals, Inc. (NKPH) Merges With Nika Biotechnology, Inc.
HENDERSON, Nev., March 20, 2024 (GLOBE NEWSWIRE) — Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc.,…
Pharmaceuticals, Biotechnology and Life Sciences
HENDERSON, Nev., March 20, 2024 (GLOBE NEWSWIRE) — Nika Pharmaceuticals, Inc. (OTCMKTS: NKPH) announces its merger with Nika BioTechnology, Inc.,…
Conference call and webcast (English) on Thursday, March 21, 2024 at 9:30am ET / 2:30pm CET Ongoing clinical efforts boding…
Company announcement – No. 17 / 2024 Zealand Pharma’s Annual General Meeting 2024 Copenhagen, March 20, 2024 – Today, Zealand…
FORT WORTH, March 20, 2024 (GLOBE NEWSWIRE) — TFF Pharmaceuticals, Inc (Nasdaq: TFFP) (the “Company” or “TFF Pharmaceuticals”), a clinical-stage…
WARREN, N.J., March 19, 2024 (GLOBE NEWSWIRE) — Aquestive Therapeutics, Inc. (NASDAQ: AQST) (“Aquestive” or the “Company”), a pharmaceutical company…
SOUTH SAN FRANCISCO, Calif., March 19, 2024 (GLOBE NEWSWIRE) — NGM Biopharmaceuticals, Inc. (NGM Bio) (Nasdaq: NGM), a biotechnology company…
– FDA and AEON align on the design and endpoints for the proposed pivotal Phase 3 trials for the preventive…
— Termination of the Forward Purchase Agreements simplifies AEON’s capitalization structure — — AEON to expand its Board of Directors…
Announced positive randomized first-line HCC data showing superiority of TPST-1120 combination therapy across multiple study endpoints compared to standard of…
WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) — Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a…